Engineering new bone growth using specific microRNAs
New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic angiogenic coupling
This study is exploring how tiny molecules called microRNAs can help grow new bone and blood vessels at the same time, which could lead to better treatments for people with large bone injuries or defects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10911001 on NIH RePORTER |
What this research studies
This research focuses on using microRNAs to enhance the growth of new bone tissue by promoting the formation of blood vessels and bone simultaneously. The approach involves targeting specific molecular pathways that regulate bone formation and resorption, aiming to develop new therapies for large bone defects. By studying the miR-23-27-24 microRNA cluster, the research seeks to understand how these molecules can be used to stimulate bone regeneration and improve healing in affected areas.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with significant bone loss or defects, such as those resulting from trauma, surgery, or certain diseases.
Not a fit: Patients with stable bone conditions or those not experiencing bone regeneration issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that significantly improve bone healing and regeneration for patients with large bone defects.
How similar studies have performed: Other research has shown promising results using microRNAs for bone regeneration, indicating that this approach has potential based on previous successes.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Luan, Xianghong — University of Rochester
- Study coordinator: Luan, Xianghong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.